Skip to main content

Table 2 Details of the patients in the AH group

From: Influence of antihypertensive medications on the clinical parameters of anodized dental implants: a retrospective cohort study

Patient Age Site Implant Diseases Maintenance Antihypertensive medication
(Sex) (months)
1 61 47 Brånemark Mk III Groovy None 25 Angiotensin II receptor blockers
(F)
2 62 24, 27, 45, 47 Brånemark Mk III Groovy None 35 Calcium antagonists
(F)
3 57 36, 37, 46 Brånemark Mk III Groovy Peri-implant mucositis [46] 52 Calcium antagonists
(M) Peri-implantitis [37] Angiotensin II receptor blockers
4 63 14, 15, 25 Replace Select Tapered Peri-implantitis [15, 25] 116 Angiotensin II receptor blockers
(F)
5 55 46, 47 Replace Select Straight Peri-implant mucositis [47] 108 Angiotensin II receptor blockers
(M)
6 77 24, 26, 27 Replace Select Tapered Peri-implant mucositis [24] 165 Calcium antagonists
(M)
7 84 15, 16, 36, 46 Replace Groovy Straight Peri-implantitis [15, 16] 153 Angiotensin II receptor blockers
(M)
8 67 16, 23, 25, 26, 36, 46 Replace Groovy Straight Peri-implant mucositis [26] 132 Calcium antagonists
(F) Peri-implantitis [16, 23, 25, 46]
9 64 25, 27 Replace Groovy Straight None 37 Calcium antagonists
(M)
10 68 13, 15 Replace Groovy Straight None 15 Angiotensin II receptor blockers
(F)
11 80 24 Replace Select Tapered Peri-implant mucositis [24] 164 Calcium antagonists
(M)
12 63 15, 16 Replace Groovy Straight Peri-implant mucositis [15] 27 Angiotensin II receptor blockers
(M) Thiazide diuretics
13 51 37 Brånemark Mk III Groovy None 28 Angiotensin II receptor blockers
(M)
  1. AH group group taking antihypertensive medications